Fintel reports that on January 30, 2025, HC Wainwright & Co. initiated coverage of Knightscope (NasdaqCM:KSCP) with a Buy ...

H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on Bioxcel Therapeutics (BTAI – Research Report) yesterday and set a price target ...

HC Wainwright increased their Q3 2025 earnings estimates for shares of Atara Biotherapeutics in a report released on Tuesday, ...

Fintel reports that on January 30, 2025, HC Wainwright & Co. downgraded their outlook for CARGO Therapeutics (NasdaqGS:CRGX) from Buy to Neutral. Analyst Price Forecast Suggests 146.36% Upside As of ...

H.C. Wainwright lowered the firm’s price target on PepGen (PEPG) to $16 from $26 and keeps a Buy rating on the shares after the company shared ...

HC Wainwright cut their FY2024 EPS estimates for GH Research in a research note issued to investors on Monday, January 27th. HC Wainwright analyst P. Trucchio now forecasts that the company will post ...

Enveric Biosciences, Inc. (NASDAQ: ENVB) ("Enveric" or the "Company"), a biotechnology company dedicated to the development ...

Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (the “Company”), a pharmaceutical company focused on developing new ...

The identity of these investors remains unknown, but such a substantial move in NNE usually suggests something big is about ...

Northern Dynasty Minerals Ltd (NAK) stock saw a decline, ending the day at $0.63 which represents a decrease of $-0.01 or -1.56% from the prior close of $0.64. The stock opened at $0.63 and touched a ...

The aggregate gross proceeds to the Company from the offering are expected to be $1.5 million, before deducting the placement agent fees and other offering expenses payable by the Company. The Company ...

We recently compiled a list of the 12 Stocks That Will Double in 2025. In this article, we are going to take a look at where CleanSpark, Inc. (NASDAQ:CLSK) stands against the other stocks.